2023. PASI Improvement in the First 12 weeks from the Phase 3 VOYAGE 1, VOYAGE 2, ORION and ECLIPSE Guselkumab Clinical Trials. SKIN The Journal of Cutaneous Medicine. 7, 6 (Nov. 2023), s237. DOI:https://doi.org/10.25251/skin.7.supp.237.